Recent Finacing
Recent Raise
Crossject is a Dijon-based medtech that has developed Zeneo, a needle-free high-pressure injection platform, and its lead product Zepizure for emergency epilepsy treatment.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Crossject.
